
KCK Group is a multi-billion AUM single-family office based in New York, managing assets for the Kassar family. The firm operates through multiple investment vehicles — including KCK Financial Services (fintech/financial services) and KCK Medtech (medical devices) — investing across life sciences, energy, industrials, and financial services from early-stage to growth and public companies.
52% of their portfolio is in Healthcare. Average disclosed round size is $59.9M (across 23 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
23 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series C | $70M | Feb 2023 | |
| Series C | $100M | Jan 2023 | |
| Series D | $95M | May 2021 | |
| Series B | $128M | Jan 2021 | |
| Growth | $48M | Aug 2020 | |
| Unknown | $67M | Jan 2020 | |
| Series A | $100M | Jan 2020 | |
| Series A | $11.6M | Jan 2020 | |
| Growth | $70M | Dec 2019 | |
| Series C | $30M | Dec 2019 | |
| Series D | $31M | Sep 2019 | |
| Series B | $30M | Sep 2018 | |
| Series C | $100M | Apr 2018 | |
| EEtaGen | Series C | $83M | Jan 2018 |
| Series A | $30M | Jun 2016 | |
| Series B | $46M | Apr 2016 | |
| Series B | $46M | Apr 2016 | |
| Growth | $100M | Jan 2016 | |
| Series A | $30M | Jan 2016 | |
| Series C | $51M | Jun 2013 | |
| Series B | $20M | — | |
| Series A | $11.6M | — | |
| Unknown | $80M | — |
Top Co-Investors
Venrock9 shared
Sofinnova Partners9 shared
Pfizer Ventures9 shared
T. Rowe Price6 shared
Ally Bridge Group6 shared
Johnson & Johnson Innovation4 shared
Bain Capital Ventures3 shared
Winklevoss Capital Management3 shared
Polychain Capital3 shared
Founders Fund3 shared
Catalio Capital Management3 shared
Bill Gates2 shared
KCK2 shared
Khosla Ventures2 shared
Exor Ventures2 shared
Upper902 shared
The Goldman Sachs Group, Inc.2 shared
Gaingels2 shared
Pine Brook2 shared
OrbiMed2 shared
Last updated: 20 October 2026